Sehrawat Anuradha, Sultana Sarwat
Section of Chemoprevention and Nutrition Toxicology, Department of Medical Elementology and Toxicology, Faculty of Science, Jamia Hamdard (Hamdard University), New Delhi 110 062, India.
Life Sci. 2006 Sep 5;79(15):1456-65. doi: 10.1016/j.lfs.2006.04.009. Epub 2006 Apr 25.
We have previously reported that Tamarix gallica caused a marked inhibition of thioacetamide-induced hepatotoxicity, oxidative damage and early tumor promotion related events in the liver. These results strongly indicates that T. gallica may have chemopreventive potential. Therefore, in the present study, we examined the inhibitory effects of T. gallica methanolic extract on diethylnitrosamine (DEN) initiated and 2-acetyl aminofluorene (2-AAF) promoted liver carcinogenesis in male Wistar rats. Interestingly, it was found that T. gallica (25 and 50 mg/kg body wt.) resulted in a marked reduction of the incidence of liver tumors. The study was further histologically confirmed. Furthermore to understand the underlying mechanisms of chemopreventive action by T. gallica we evaluated the levels activities of hepatic antioxidant defense enzymes, ornithine decarboxylase activity and hepatic DNA synthesis as a marker for tumor promotion since direct correlation between these marker parameters and carcinogenicity have been well documented. Treatment of male Wistar rats for five consecutive days with 2-AAF i.p. induced significant hepatic toxicity, oxidative stress and hyperproliferation. Pretreatment of T. gallica extract (25 and 50 mg/kg body wt.) prevented oxidative stress by restoring the levels of antioxidant enzymes and also prevented toxicity at both the doses. The promotion parameters induced (ornithine decarboxylase activity and DNA synthesis) by 2-AAF administration in diet with partial hepatectomy (PH) were also significantly suppressed dose-dependently by T. gallica. Therefore, we can conclude that ultimately the protection against liver carcinogenesis by T. gallica methanolic extract might be mediated by multiple actions, which include restoration of cellular antioxidant enzymes, detoxifying enzymes, ODC activity and DNA synthesis.
我们之前曾报道, Tamarix gallica(没食子酸)对硫代乙酰胺诱导的肝毒性、氧化损伤以及肝脏中早期肿瘤促进相关事件具有显著抑制作用。这些结果有力地表明,没食子酸可能具有化学预防潜力。因此,在本研究中,我们检测了没食子酸甲醇提取物对雄性Wistar大鼠二乙基亚硝胺(DEN)启动及2-乙酰氨基芴(2-AAF)促进的肝癌发生的抑制作用。有趣的是,发现没食子酸(25和50毫克/千克体重)可显著降低肝肿瘤的发生率。该研究进一步得到了组织学证实。此外,为了解没食子酸化学预防作用的潜在机制,我们评估了肝脏抗氧化防御酶的水平和活性、鸟氨酸脱羧酶活性以及肝脏DNA合成,以此作为肿瘤促进的标志物,因为这些标志物参数与致癌性之间的直接关联已得到充分记录。用2-AAF腹腔注射连续五天处理雄性Wistar大鼠会诱导显著肝毒性、氧化应激和细胞过度增殖。没食子酸提取物预处理(25和50毫克/千克体重)通过恢复抗氧化酶水平预防了氧化应激,并且在两个剂量下均预防了毒性。在部分肝切除(PH)饮食中给予2-AAF所诱导的促进参数(鸟氨酸脱羧酶活性和DNA合成)也被没食子酸剂量依赖性地显著抑制。因此,我们可以得出结论,最终没食子酸甲醇提取物对肝癌发生的保护作用可能是由多种作用介导的,这些作用包括恢复细胞抗氧化酶、解毒酶、ODC活性和DNA合成。